Matthew Sinnreich - 21 Jul 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role: COO and Acting CEO
Signature: /s/ Matthew Sinnreich
Issuer symbol: OCEL
Transactions as of: 21 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 26 Jul 2022, 16:05:46 UTC
Next filing: 17 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	OCEL	Common Stock, $0.001 par value						10,000,000	21 Jul 2022	Direct	F1
holding	OCEL	Common Stock, $0.001 par value						24,000,000	21 Jul 2022	Direct	F2
holding	OCEL	Common Stock, $0.001 par value						6,996,000	21 Jul 2022	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	OCEL	Warrants to Purchase Common Stock							21 Jul 2022	Common Stock, par value $0.001 per share	40,000,000	$0.0340	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock and warrants to purchase common stock issued to the Reporting Person as a signing bonus in connection with his employment as the Issuer's Chief Operating Officer and Acting Chief Executive Officer.
F2	Represents shares of common stock issued to the Reporting Person as compensation during for his first year of employment. The shares vest in twelve monthly installments of 2,000,000 shares each, subject to continued employment.
F3	Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.